Feugiat nulla facilisis at vero eros et curt accumsan et iusto odio dignissim qui blandit praesent luptatum zzril.
+ (123) 1800-453-1546
info@example.com

Related Posts

Products

NEFA

Non-Esterified Fatty Acids (NEFA) can be used for evaluating the metabolic status of people with endocrinopathies. It can be used for the detection of Pheochromocytoma and of glucagon, thyrotropin and andrenocorticotropin secreting tumours. It is also occassionally used for monitoring of control of diabetes mellitus.

Biorex Diagnostics manufactures LDH reagents designed for CA 180/270/400 Furuno/Daytona systems.

Add to Quote

Description

Product Name Details CAT.No Size
NEFA (L.S) Suitable for CA 180/270/400 Furuno/ Daytona Series Reagents BXCF477A R1: 1 x 40ml R2: 1 x 10ml CAL: 1 x 1ml

 

 

Product Description

The Biorex Diagnostics NEFA assay is an in vitro diagnostic test for the quantitative determination of Non-Esterified Fatty Acids (NEFA) in human serum and plasma. NEFA are key energy substrates and indicators of metabolic function.

Key Features
• Quantitative measurement of NEFA in serum and plasma
• Sensitive marker for metabolic and endocrine disorders, including diabetes and hormone-secreting tumors
• Enzymatic method ensures high accuracy, sensitivity, and reproducibility
• Supports metabolic monitoring and treatment evaluation
• Compatible with CA 180/270/400 Furuno/Daytona systems

Benefits
The Biorex NEFA Assay provides precise, reliable, and clinically meaningful results for evaluating lipid mobilization, metabolic status, and endocrine function. Its automated compatibility and sensitivity make it essential for clinical laboratories, hospital diagnostics, and metabolic research.

Additional information

Storage

2-8°C